Interleukin-37 Inhibits Colon Carcinogensis During Chronic Colitis

Inflammatory bowel disease increases the risk of developing colon cancer. Interleukin (IL-) 37 is a fundamental inhibitor of innate immunity by reducing systemic and local inflammation. IL-37 protein is expressed in healthy and diseased bowel and liver tissue. Here, we tested whether transgenic expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mountford, Steffeni, Ringleb, Andrea, Schwaiger, Rahel, Mayr, Doris, Kobold, Sebastian, Dinarello, Charles A., Bufler, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857648/
https://www.ncbi.nlm.nih.gov/pubmed/31781119
http://dx.doi.org/10.3389/fimmu.2019.02632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857648/
https://www.ncbi.nlm.nih.gov/pubmed/31781119
http://dx.doi.org/10.3389/fimmu.2019.02632

Ejemplares similares